A record 113 million viewers tuned into the Super Bowl this year.
That means a record number of them heard the 30-second commercial from a pharmaceutical company talking about menopause, which is not the usual Super Bowl ad fodder.
The company spreading the word about hormone therapy is on the right track to make money. A bit part of the so-called menopause gold rush revolves around the revival of hormone therapy.
Product lines for menopause and post menopausal people are coming out of the woodwork.
Half of the world’s population will experience menopause at some point in their lives. One million women in the U.S. alone start menopause every year, but what do they know about the condition?
Not much because menopause is undertreated and not a big topic of conversation. For the last two decades, many among us in the U.S. have been forced to grin and bear it and encouraged to somehow turn back the clock.
That’s not necessarily the case in many other cultures, where aging is associated with wisdom and reverence.
We’re talking about menopause, the stigma, and new treatment options.
Guests:
- Rebecca Thurston, director of the Women’s Biobehavioral Health Program at the University of Pittsburgh
- Melissa Melby, professor of medical anthropology at the University of Delaware
If you have a disability and would like a transcript or other accommodation you can request an alternative format.